Saved in:
| Main Author: | Mamoor, Shahan |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2025
|
| Online Access: | https://doi.org/10.5281/zenodo.15527143 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Deletion of repeat B and C of Xist results in induction of SATB1.
by: Mamoor, Shahan
Published: (2026)
by: Mamoor, Shahan
Published: (2026)
Telomerase control of Xist through Trf2.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Xist is activated during resistance in triple negative breast cancer in vitro.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
The range of Xist transcriptional targets in non-small cell lung cancer: MYC.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
The genes encoded at the Dxz locus, DANT2/3, are components of an Xist gene expression regulation apparatus that utilizes quantitative control of message quantity of specific genes to measure and maintain transcription, globally, within homeostatic range.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
An epigenetic module common to the T lymphocyte.
by: Mamoor, Shahan
Published: (2026)
by: Mamoor, Shahan
Published: (2026)
Feedback activation of VEGF-A resulting from PAX8 inhibition in cancer cells.
by: Mamoor, Shahan
Published: (2026)
by: Mamoor, Shahan
Published: (2026)
A retrotransposon-like gene, RTL5, is modulated during differentiation of embryonic stem cells to the trophectoderm lineage.
by: Mamoor, Shahan
Published: (2026)
by: Mamoor, Shahan
Published: (2026)
NLRP7 engagement in transformation and etiology of chronic disease.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: TGFBI.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MTF1.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Importin 8 is activated in childhood brain cancer.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: MAT1A.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Phosphatase targeting in Luminal B breast cancer: PGP.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Matrix metalloproteinases MMP1/MMP9 function in melanoma resistance.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Phosphatase targeting in Luminal B breast cancer: PNKP.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Clec2b and Clec11a, co-receptors for KIR2DL3 natural killer cell self discrimination complexes, are altered in expression in the cells of patients with IBD.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: SRC.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
ABC transporter multi-drug resistance genes ("pumps") in humans with non-small cell lung cancer.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
HSC, CMP and CLP in mice.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MYO9B.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: NFATC1.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Aire is a component gene of the Th17 gene signature.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: GDF5.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: INPP5F.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
A comprehensive description of the circulating tumor cell: TM6SF1.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
FCGRT functions in senescence and transformation.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of liver metastasis: ACSM2B.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Leukotriene activation in the blood of humans with high CRP.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
TSC22D4 gene activation in Crohn's Disease.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Glucocorticoid resistance features changes in general transcription factor (GTF) expression.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Genes expressed in the CD4 + T lymphocyte.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: ATG13.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Kinase activation during small molecule inhibition of the receptors for the vascular endothelial growth factors VEGFR1 and VEGFR2.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Ribosomal activation in TNBC resistance in vitro.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
MAP3K6 functions in compensatory feedback signaling during clinical interventions featuring use of the VEGF-A inhibitor bevacizumab.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
SSX2IP induction in basal subtype breast cancer.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Similar Items
-
Deletion of repeat B and C of Xist results in induction of SATB1.
by: Mamoor, Shahan
Published: (2026) -
Telomerase control of Xist through Trf2.
by: Mamoor, Shahan
Published: (2025) -
Xist is activated during resistance in triple negative breast cancer in vitro.
by: Mamoor, Shahan
Published: (2025) -
The range of Xist transcriptional targets in non-small cell lung cancer: MYC.
by: Mamoor, Shahan
Published: (2025) -
The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
by: Mamoor, Shahan
Published: (2025)